Healthcare -
Biotechnology - NASDAQ - GB
$ 0.53
-1.85 %
$ 22.6 M
Market Cap
-3.12
P/E
ADAP - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ADAP - Adaptimmune Therapeutics plc
177 M
LAST VALUE
52.61%
2 YEAR CAGR
64.68%
5 YEAR CAGR
101.58%
10 YEAR CAGR